Ranbaxy suffers 53% fall in US sales
Health / Medicine Related News
India's largest drugsmaker continues to feel the financial pain inflicted by an import ban on some of its products amid efforts to resolve its row with the US Food and Drug Administration
Source: FT.com - Pharmaceuticals
More bad news for business in India. I was looking for specifics about why the FDA disapproved byt all I got from the link was this: